All Updates

All Updates

icon
Filter
Funding
Midi Health raises USD 60 million in Series B funding to expand services and operations
Preventive Healthcare
Apr 24, 2024
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Preventive Healthcare

Preventive Healthcare

Apr 24, 2024

Midi Health raises USD 60 million in Series B funding to expand services and operations

Funding

  • Healthcare provider specializing in women's midlife health Midi Health has raised USD 60 million in a Series B funding round led by Emerson Collective, with participants including Google Ventures, Memorial Hermann, SemperVirens, Felicis, Icon Ventures, Black Angel Group, and Gingerbread Capital. This round brings the total funds raised by Midi Health to USD 100 million.

  • The new funds will increase insurance coverage and hire and provide additional training to 150 clinicians by the end of the year. The organization plans to diversify service lines, amplify the midlife women's healthcare discussion, and scale its operations to care for over 1 million women annually by 2029. 

  • Analyst QuickTake: The company is leading the way in delivering expert and insurance-friendly healthcare to women in perimenopause and menopause stages. Last October , it announced that it would expand its virtual care clinic to employers in all 50 states beginning in January 2024. In March 2024 , the company partnered with Neurotrack to help women determine whether brain fog symptoms are indicative of menopause or signs of severe cognitive impairment such as early dementia. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.